Advertisement
ARQT 外匯新聞
Arcutis Biotherapeutics Appoints David Topper To Succeed John Smither As CFO
Medical dermatology company Arcutis Biotherapeutics, Inc. (ARQT) announced Wednesday that David Topper has been appointed Chief Financial Officer (CFO) effective April 10, 2024. Topper is replacing John Smither, who rejoined Arcutis as interim CFO in August 2023. Smither will remain at Arcutis through the end of April to ensure a smooth transition.
RTTNews
|
487天前
Arcutis Says Health Canada Accepts For Review Roflumilast Cream NDS For Plaque Psoriasis
Arcutis Biotherapeutics, Inc. (ARQT) announced Monday that Health Canada has accepted for review the New Drug Submission (NDS) for roflumilast cream 0.3% for the treatment of plaque psoriasis in adults and adolescents. The target action date is April 30, 2023.
RTTNews
|
1126天前
